AbCellera Biologics (ABCL) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.17
-0.15
-0.14
-0.12

Details

Expected EPS
-0.136133
Actual EPS
-0.15
Surprise EPS
-0.01
Surprise Percent
+10.19%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.15 per share for Q2 2025.

0 Comments

Share your thoughts